myocardial infarction
QuidelOrtho Gets Canadian Approval for Point-of-Care High-Sensitivity Troponin Test
The immunoassay detects a subunit of the troponin complex released by heart muscle cells after a myocardial infarction.
Ortho Clinical Diagnostics, Hangzhou AllTest Biotech, Others Obtain FDA Clearances in January
Ortho got the green light for a reagent pack used to measure creatine kinase myocardial band on the firm's Vitros 3600 Immunodiagnostic System.
The amplification-free platform uses miRNAs in its ion-exchange platform to return results in less than 30 minutes.
Prevencio, Atlas Genomics to Commercialize Cardiac Blood Tests
The tests use Microsoft's Azure AI-based computing cloud platform for test algorithm processing and scoring and for report generation and delivery.
Siemens Healthineers Gets CE Mark for Point-of-Care High-Sensitivity Cardiac Troponin I Test
The technology underlying the test was developed by Dutch firm Minicare, which was acquired by Siemens in 2019.
Mar 16, 2020
May 17, 2019
Jun 27, 2018
FDA Clears Beckman Coulter Troponin Assay
Nov 7, 2017